SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-148219
Filing Date
2021-05-03
Accepted
2021-05-03 17:20:02
Documents
9
Period of Report
2021-05-03

Document Format Files

Seq Description Document Type Size
1 6-K d180388d6k.htm 6-K 20300
2 EX-5.1 d180388dex51.htm EX-5.1 23522
3 EX-10.1 d180388dex101.htm EX-10.1 74135
4 EX-10.2 d180388dex102.htm EX-10.2 127099
5 EX-10.3 d180388dex103.htm EX-10.3 195108
6 EX-99.1 d180388dex991.htm EX-99.1 28228
7 GRAPHIC g180388g0501003321351.jpg GRAPHIC 3188
8 GRAPHIC g180388g0501013551703.jpg GRAPHIC 4134
9 GRAPHIC g180388g0501013551890.jpg GRAPHIC 4142
  Complete submission text file 0001193125-21-148219.txt   485807
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 21884732
SIC: 2836 Biological Products, (No Diagnostic Substances)